Rat cell-derived kidney generation via interspecies blastocyst complementation in an Osr1-KO mouse model Authors: Shunsuke Yuri, Ayako Isotani Published: 2026 ABSTRACT SummaryInterspecies blastocyst complementation (BC) provides a promising approach to generate transplantable organs from pluripotent stem cells (PSCs). However, interspecies kidney generation has remained largely unsuccessful, particularly when using rat PSCs in mouse hosts. Here, we investigated multiple renal-deficient models (Sall1-, Ret-, and Osr1-knockouts [KOs]) through reverse BC (rBC) analyses. We identified Osr1-KO embryos as lacking both nephron progenitor and ureteric bud lineages, providing a vacant developmental niche for renal reconstruction. Injection of rat embryonic stem cells (ESCs) into Osr1-KO mouse blastocysts led to robust rat cell contribution and the formation of kidneys predominantly composed of rat in the vacant niche. These findings establish the Osr1-KO model as a permissive platform for interspecies kidney organogenesis and offer mechanistic insight into developmental compatibility underlying xenogeneic organ generation.Keywords: kidney development, kidney regeneration, blastocyst complementation, interspecies chimera Introduction The kidneys are essential for maintaining homeostasis by filtering metabolic waste and regulating water, electrolytes, and pH balance (McMahon 2016). Chronic damage from conditions such as diabetes or hypertension leads to irreversible loss of kidney function, as renal tissue has limited regenerative capacity. Kidney transplantation is the most effective treatment for end-stage renal disease, offering superior outcomes to dialysis (Wolfe et al., 1999). However, its use is limited by donor shortages, recipient eligibility, and the complications associated with immunosuppressive therapy (Pascual et al., 2002). While the use of genetically modified porcine organs offers a compelling strategy to mitigate the global organ shortage, substantial immunological challenges associated with human xenotransplantation have yet to be overcome (Griffith et al., 2022; Montgomery et al., 2022; Zhou et al., 2022). The advent of induced pluripotent stem cells (iPSCs) has propelled efforts to generate functional organs from patient-derived cells (Takahashi and Yamanaka et al., 2006; Takahashi et al., 2007). In particular, the generation of transplantable kidneys from pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and iPSCs, represents an attractive strategy. However, despite substantial progress in deriving renal structures ex vivo from PSCs (Freedman et al., 2015; Takasato et al., 2015; Taguchi and Nishinakamura, 2017; Tanigawa et al., 2022), the generation of fully functional, three-dimensional, and size-matched kidneys remains a major challenge. To solve the problems, the blastocyst complementation (BC) method is a promising technique to generate three-dimensional organs from PSCs (Barlabé et al., 2025; Bigliardi et al., 2025). In this method, PSCs are injected into blastocysts of organ-deficient animals, allowing the PSCs to occupy the vacant developmental niche and form the missing organ. BC has since been applied in intraspecies models to generate not only kidneys but also forebrain, hematoendothelial tissues, lungs, thyroids, and livers (Usui et al., 2012; Matsunari et al., 2020; Chang et al., 2018; Hamanaka et al., 2018; Ran et al., 2020; Ruiz-Estevez et al., 2021; Wen et al., 2021; Miura et al., 2023). Interspecies BC using mouse-rat combinations has also succeeded in producing organs such as pancreas, thymus, kidney, germ cells, lung, heart, forebrain, and sensor neurons (Kobayashi et al., 2010, 2021; Isotani et al., 2011; Yamaguchi et al., 2017; Goto et al., 2019; Zvick et al., 2022; Coppiello et al., 2023; Yuri et al., 2024a, 2024b; Huang et al., 2024; Throesch et al., 2024). Notably, mouse PSCs can generate kidneys in kidney-deficient rat hosts, but there have been no reports on the generation of kidneys derived from rat PSCs in mouse host (Usui et al., 2012; Goto et al., 2019), indicating a directional limitation in interspecies kidney generation. The mammalian kidney is a highly complex organ composed of numerous distinct cell types (McMahon 2016; Combes et al., 2019). It develops from the metanephros, which arises from the posterior intermediate mesoderm (IM) around embryonic day 10.5 (E10.5) in mice (Saxén 1987; Sukhatme 2003). Kidney organogenesis begins with glial cell line-derived neurotrophic factor (GDNF) expression in the metanephric mesenchyme (MM), inducing ureteric bud (UB) outgrowth from the nephric duct (Moore et al., 1996; Pichel et al., 1996). Reciprocal interactions between the UB and the cap mesenchyme (CM)—which contains Six2+ nephron progenitor cells (NPCs)—are essential for nephron induction and NPC self-renewal (Boyle et al., 2008; Kobayashi et al., 2008; Costantini and Kopan 2010). With each UB branching, subsets of CM cells undergo mesenchymal-to-epithelial transition (MET) to form renal vesicles, which develop into nephrons (Carroll et al., 2005). Adjacent to the CM is a population of Foxd1+ stromal progenitors, which generate interstitial lineages—including renin cells, smooth muscle cells, perivascular fibroblasts, and pericytes (Hatini et al., 1996; Sequeira-Lopez et al., 2015)—and support NP maintenance (Boivin et al., 2015). Sall1 plays a crucial role in kidney organogenesis by maintaining the self-renewal capacity and undifferentiated state of NPCs within the CM (Nishinakamura et al., 2001). Sall1 is highly expressed in the CM, and its loss results in severe renal hypoplasia or agenesis due to impaired NPC maintenance and defective UB branching. The Ret gene encodes the receptor tyrosine kinase RET, which is essential for the initiation and branching morphogenesis of the UB. Upon binding its ligand Gdnf, Gdnf-Ret signaling promotes UB outgrowth from the nephric duct and supports iterative branching within the MM. Disruption of the Ret gene leads to failure of UB induction and subsequent kidney agenesis, highlighting its pivotal role in early kidney induction and morphogenesis (Schuchardt et al., 1994, 1996). Osr1 is a transcription factor expressed broadly in the IM that later becomes restricted to the MM. Osr1 functions upstream of several key kidney developmental regulators, including Pax2, Six2, Eya1, and Gdnf (James et al., 2006). Osr1 is essential for the specification and survival of NPCs, and its loss leads to apoptosis of the MM and complete absence of kidney formation. Thus, Osr1 acts as a master regulator of early kidney lineage commitment. In this study, we aimed to generate rat PSC-derived kidneys using the interspecies BC method in a mouse model, which is not achieved in the previous study (Usui et al., 2012). To establish a suitable organ-deficient host for kidney generation, we evaluated mouse kidney knockout (KO) models such as Sall1-KO, Ret-KO, and Osr1-KO, using the reverse BC (rBC) method—in which genetically modified PSCs are injected into wild-type (WT) blastocysts to assess chimeras composed of mutant and wild-type cells during organogenesis (Yuri et al., 2024a, 2024b)—to determine their suitability and the conditions required for kidney generation. Finally, we successfully generated rat-derived kidneys in the kidney-deficient mouse model via the interspecies BC method. Results Analysis of the Sall1-deficient mouse model in the rBC method To elucidate the requisite conditions for kidney generation using the BC method, we first investigated the Sall1-KO model previously described in kidney generation with the BC method (Usui et al., 2012; Goto et al., 2019). To investigate the Sall1-KO model with the rBC method (Figure 1A), we used mutant mouse ESCs constitutively expressing red fluorescent protein (RFP), similar to our previous report (Yuri et al., 2024a, 2024b). We designed two guide RNAs (gRNAs) to excise the entire exon regions of the Sall1 gene, thereby establishing Sall1-KO mouse ESCs (Figure S1A). The successful excision of the Sall1 gene was validated via PCR and sequencing analyses (Figure S1B). Seven Sall1-KO ESC lines were used to analyze the chimeras (Figure S1C). Sall1-KO mouse ESCs were injected into WT mouse embryos (donor: mouse; host: mouse) and analyzed at E14.5 (Table S1). Chimeras comprising 1.4%–16.6% WT (RFP-) cells were not able to develop kidneys (n = 11) (Figures 1B and S1D), mirroring the phenotype observed in Sall1-KO mice (Nishinakamura et al., 2001). Conversely, chimeras containing 7.2%–97.2% WT (RFP−) cells exhibited 2 kidneys (n = 41), suggesting that a minimum threshold of 7.2%–16.6% WT cell contribution to the chimeras is required for kidney generation in the Sall1-KO model (Figure 1B). In the WT ESC (RFP+) injection analysis, all of the chimeras containing 0.7%–98.6% WT (RFP-) cells contained 2 kidneys (n = 33) (Figure 1B). Immunofluorescence analysis of Sall1-KO (RFP+) cells within renal component tissues demonstrated that Sall1-KO cells were incapable of contributing to Six2+ NPCs (Figure 1C). Nevertheless, Sall1-KO cells were able to contribute into E-Cad+ UB cells in the peripheral region of the kidney, Pbx1+ stromal-derived cells, and Endomucin+ endothelial cells (Figures 1C and 1D). These findings suggest that WT cells predominantly contributed to the nephron progenitor population in the Sall1-KO model. Analysis of the Sall1-KO model in kidney with the reverse blastocyst complementation method (A) Schematic of the reverse-blastocyst complementation (rBC) method. Sall1-knockout (KO) mouse embryonic stem cells (ESCs) expressing red fluorescent protein (RFP) were injected into the mouse wild-type (WT) embryo (donor: mouse; host: mouse). Chimeras derived from Sall1-KO and WT cells were dissected to determine whether the kidney was present. (B) Relationship between the cellular contribution rate of the WT cells (host) in tail and the number of the kidney in WT-Sall1-KO ESC chimera or WT-WT ESC chimera. WT-Sall1-KO ESC chimera without kidney (n = 11) and with kidney (n = 41), or WT-WT ESC chimera with kidney (n = 37) were analyzed. (C) Representative immunostaining image of E-Cad, Six2, Pbx1, and Endomucin in kidney of WT-Sall1-KO ESC chimeras. White arrows indicate that Sall1-KO cells localized at E-Cad, Pbx1, and Endomucin-positive cells, respectively. Scale bars, 50 μm. (D) Quantification of Sall1-KO cell labeling in Six2+, E-Cad+, Pbx1+, and Endomucin+ cell populations (4–6 different nonoverlapped regions were analyzed in each marker, n = 2 chimeras). Statistical analyses: unpaired Student’s t test, significance at ∗p < 0.05, ∗∗p < 0.01. Error bars represent mean ± standard deviation (SD). Analysis of Ret- and Ret/Sall1-deficient models in the rBC method Next, we focused on the UB tissue, another key component of kidney development. Considering less competitive ability of Ret-KO cells relative to WT cells within UB tissue (Shakya et al., 2005; Riccio et al., 2016), we also undertook an analysis using the Ret-KO model in the rBC method. To establish Ret-KO mouse ESCs, the GFP gene was introduced into the Ret gene locus (Figure S2A), resulting in the establishment of three distinct Ret-KO ESC clones (Figures S2B–S2D). When Ret-KO ESCs were injected into WT mouse embryos (donor: mouse; host: mouse) and analyzed at E14.5 (Table S2), chimeras comprising 0.8%–2.6% WT cells were unable to develop kidneys (n = 13), reflecting the phenotype observed in Ret-KO mice (Schuchardt et al., 1994, 1996) (Figure 2A). On the other hand, chimeras containing 2.1%–12.9% WT cells exhibited 1 kidney (n = 4), and chimeras containing 16.3%–98.9% WT cells exhibited 2 kidneys (n = 49) (Figure 2A). These results indicate that a minimum threshold of approximately 2% of WT cells is required for at least one of the kidneys to develop in the Ret-KO model. Immunofluorescence analysis showed that Ret-KO cells were not specifically observed in E-Cad+ UB tissues (Figures 2B and 2C). Conversely, Ret-KO cells were capable of contributing to NPCs, as well as to stromal and endothelial tissues (Figures 2B and 2C). Together, these results demonstrate that WT cells predominantly complement UB-derived tissues in the kidneys of the Ret-KO model. Analysis of Ret-KO and Ret/Sall1-DKO models in kidney using the rBC method (A) Relationship between the cellular contribution rate of the WT cells (host) in tail and the number of the kidney in WT-Ret-KO ESC chimeras. WT-Ret-KO ESC chimeras without kidney (n = 13), with 1 kidney (n = 4), and with 2 kidneys (n = 53) were analyzed. (B) Representative immunostaining image of E-Cad, Six2, Pbx1, and Endomucin in kidney of WT-Ret-KO ESC chimeras. White arrows indicate that Ret-KO (RFP+) cells localized at Six2, Pbx1, or Endomucin-positive cells, respectively. Scale bars, 50 μm. (C) Quantification of Ret-KO cells labeling in Six2+, E-Cad+, Pbx1+, and Endomucin+ cell population (6–10 different nonoverlapped regions were analyzed in each marker, n = 2 chimeras). Statistical analyses: unpaired Student’s t test, significance at ∗p < 0.05, ∗∗p < 0.01. Error bars represent mean ± standard deviation (SD). (D) Relationship between the cellular contribution rate of the WT cells (host) in tail and the number of the kidney in WT-Ret/Sall1-DKO ESC chimeras. WT-Ret/Sall1-DKO ESC chimeras without kidney (n = 9), with 1 kidney (n = 2), and with 2 kidneys (n = 38) were analyzed. (E) Representative immunostaining image of E-Cad, Six2, Pbx1, and Endomucin in kidney of Ret/Sall1-DKO and WT cell chimeras. White arrows indicate that Ret/Sall1-KO cells localized at Pbx1 or Endomucin-positive cells, respectively. Scale bars, 50 μm. (F) Quantification of Ret/Sall1-DKO cell labeling in Six2+, E-Cad+, Pbx1+, and Endomucin+ cell populations (9 different nonoverlapped regions were analyzed in each marker, n = 3 chimeras). Statistical analyses: unpaired Student’s t test, significance at ∗∗p < 0.01. Error bars represent mean ± standard deviation (SD). To further assess the efficacy of the rBC method in a two-gene KO model, we generated Ret/Sall1 double-KO (DKO) mouse ESCs. We introduced mutations into the Ret gene within Sall1-KO ESCs and successfully established three Sall1/Ret-DKO ESC lines (Figure S2E). When these Ret/Sall1-DKO ESCs were injected into WT mouse embryos (donor: mouse; host: mouse) and analyzed at E14.5 (Table S2), it was determined that chimeras containing 0.9%–2.7% WT cells exhibit 0 kidney (n = 9), while the chimeras containing 6.4% or 20.6% showed 1 kidney (n = 2) and chimeras containing 23.7%–99.9% of WT cells exhibited 2 kidneys (n = 38) (Figure 2D). Notably, Ret/Sall1-DKO cells failed to contribute to either NPCs (Six2+) or UB cells (E-Cad+) (Figures 2E and 2F), demonstrating a combined negative effect of the Sall1-KO and Ret-KO phenotypes. Collectively, these results indicate that the rBC method can effectively elucidate kidney-defective models carrying multiple gene mutations. Analysis of the Osr1-KO model in the rBC method Given that the Osr1 gene is expressed in IM cells, which are thought to be progenitors of most of kidney component cells (Mugford et al., 2008), and that the Osr1-KO mouse exhibits abnormalities in the nephric duct and NPCs (James et al., 2006), we utilized the rBC method to assess the competitive ability of Osr1-KO cells against WT cells during kidney development. Using blastocysts obtained from the Osr1-GFP and Osr1-Cre mouse lines established in this study (Figures S3A and S3B), we established seven RFP-expressing Osr1-KO ESC lines and one WT ESC line. When these Osr1-KO mouse ESCs were injected into WT mouse embryos (donor: mouse; host: mouse) and analyzed at E12.5 (Table S3), two kidneys were observed in the chimeras containing 28.6%–91.7% WT cells (n = 37), one kidney was seen in the chimeras containing 10.6%–32% WT cells (n = 5), and no kidneys were detected when 0.5%–31.3% WT cells (n = 25) were present in the chimera consisting of Osr1-KO and WT cells (Figure 3A). In contrast, chimeras containing WT ESC-derived cells consistently showed two kidneys (n = 12) (Figure 3A). Immunofluorescence analysis indicated that Osr1-KO cells were conspicuously absent from the UB cells (E-Cad+) and NPCs (Six2+) but were present in the stromal cells (Pbx1+) and endothelial cells (Endomucin+) (Figures 3B and 3C). These results suggest that approximately 10% of WT cells are sufficient to generate at least one kidney and that WT cells predominantly form the NPCs and UB tissues in the kidneys of the Osr1-KO model. Analysis of the Osr1-KO model using the rBC method (A) Relationship between the cellular contribution rate of the WT cells (host) in tail and the number of the kidney in WT-Osr1-KO ESC chimeras or WT-WT ESC chimeras. WT-Osr1-KO ESC chimera without kidney (n = 25), with 1 kidney (n = 5), with 2 kidneys (n = 37), and with 3 kidneys (n = 1) and WT-WT ESC chimeras with 2 kidneys (n = 12) were analyzed. (B) Representative immunostaining image of E-Cad, Six2, Pbx1, and Endomucin in kidney of Osr1-KO and WT cell chimeras. White arrows indicate that Osr1-KO cells localized at E-Cad, Pbx1, or Endomucin-positive cells, respectively. Scale bars, 50 μm. (C) Quantification of Osr1-KO cell labeling in Six2+, E-Cad+, Pbx1+, and Endomucin+ cell population (6–7 different nonoverlapped regions were analyzed in each marker, n = 4 chimeras). Statistical analyses: unpaired Student’s t test, significance at ∗p < 0.05, ∗∗p < 0.01. Error bars represent mean ± standard deviation (SD). Analysis of the Osr1-KO model in the BC method Subsequently, we assessed the Osr1-KO model using the intraspecies BC method. RFP-expressing WT mouse ESCs were injected into the Osr1-KO blastocysts obtained from Osr1-heterozygous mouse crossing (donor: mouse; host: mouse). Due to the inclusion of WT ESC-derived cells in the chimeras, which complicates genotype analysis, two distinct Osr1 heterozygous mouse lines, Osr1-GFP and Osr1-Cre, were used for the intraspecies BC method (Figure 4A). When both Osr1-GFP and Osr1-Cre bands were detected in PCR analysis, the chimera was classified as the Osr1-KO genotype (Figures 4B and S3C). When analyzing the chimeras at E12.5–E14.5 (Table S4), 10.8%–85.8% WT cell contribution to the chimeras was necessary to generate two kidneys (n = 17), while 0%–31% WT cell contribution from ESCs exhibited no kidney (n = 11) in the Osr1-KO genotype (Figure 4C), suggesting that chimeras containing more than 10% WT cells could sometimes generate kidney, but more than 30% WT cells mostly could generate kidney in the Osr1-KO model. In contrast, 2 kidneys were present in the WT (n = 45), Osr1-Cre (n = 45), and Osr1-GFP (n = 40) genotypes in all embryos with or without WT cell-derived ESCs (Figure 4C). In Osr1-GFP embryos, GFP signals were observed in tissues expressing Osr1 (Figure S3D); however, GFP signals were absent in the kidneys of chimeras with the Osr1-KO (Cre/GFP) genotype (Figure 4D), indicating that NPCs expressing Osr1 were predominantly replaced by WT cells derived from the injected ESCs. To further examine kidney tissues, we performed immunostaining for E-Cad, Six2, Pbx1, and Endomucin in kidneys from the Osr1-KO genotype chimeras. Immunostaining analysis revealed that RFP-expressing WT cells were predominant in nearly all kidney tissues; however, detecting host cells that lacked fluorescent protein expression proved challenging (Figure 4E). To determine which tissues were complemented by the injected WT ESCs in the kidney, we sorted the RFP-positive population derived from injected ESCs and the RFP-negative population from host cells, conducting reverse-transcription PCR (RT-PCR) analysis (Figure 4F). The analysis showed that expression levels of Six2 and Ret were significantly lower in the RFP-negative cell population in the Osr1-KO genotype compared to that in the non-Osr1-KO genotype (Figure 4G). Conversely, Foxd1 and Pecam1, endothelial cell markers, did not exhibit significant differences between Osr1-KO and non-Osr1-KO genotypes (Figure 4G). These findings suggest that the injected WT ESCs effectively reconstituted the nephron progenitor and UB compartments in the Osr1-KO model, corroborating the outcomes obtained with the rBC method. Intraspecies BC method-generated kidney via the Osr1-KO mouse model (A) Schematic of the intraspecies blastocyst complementation (BC) method. Red fluorescent protein (RFP)-expressing mouse WT ESCs were injected into the embryos obtained by crossing Osr1-GFP heterozygous mouse and Osr1-Cre heterozygous mouse (donor: mouse; host: mouse). Chimeras were dissected at E12.5–E14.5. (B) Genotype results of intraspecies blastocyst complementation. (C) Relationship between the cellular contribution rate of the injected WT cells in tail and the number of the kidney in WT-WT ESC chimeras, Osr1-Cre-WT ESC chimeras, Osr1-GFP-WT ESC chimeras, or Osr1-KO-WT ESC chimeras. WT-WT ESC chimeras with 2 kidneys (n = 45), Osr1-Cre-WT ESC chimeras with 2 kidneys (n = 45), Osr1-GFP-WT ESC chimera with 2 kidney (n = 40), or Osr1-KO-WT ESC chimeras with 2 kidneys (n = 17) and 0 kidney (n = 11) were analyzed. (D) Representative kidney images obtained from Osr1-GFP-WT or Osr1-KO-WT chimeras. Scale bars, 500 μm. (E) Representative immunostaining image of E-Cad, Six2, Pbx1, and Endomucin in kidney of Osr1-KO and WT cell chimeras. Scale bars, 100 μm. (F) Schematic of the fluorescence-activated cell sorting experiment. Kidneys obtained from chimeras were dissociated and sorted into RFP+ and RFP− population. RFP+ population derived from injected ESCs and RFP− population derived from host cells. Each sorted RFP+ and RFP− cells were performed with quantitative reverse-transcription polymerase chain reaction (RT-qPCR) analysis. (G) RT-qPCR analysis of kidney derived from Osr1-KO chimeras or non-Osr1-KO chimeras to examine the expression of Six2, Ret, Foxd1, and Pecam. All data were normalized by Gapdh, and each gene expression was compared between the RFP− population and RFP+ populations. Each plot data were obtained from different chimeras (Osr1-KO: n = 4 chimeras, non-Osr1-KO: n = 9 chimeras). Error bars represent mean ± standard deviation (SD). ∗∗p < 0.01; unpaired two-tailed Student’s t test. Analysis of the Osr1-KO model in the interspecies BC method Given that chimeras comprising over 10% WT cells in the Osr1-KO model have demonstrated the capacity to generate at least one kidney, and considering that the rat contribution to the kidney occasionally surpassed this threshold (Figure S4A), we then applied the Osr1-KO model to an interspecies BC method to ascertain whether rat ESCs could facilitate kidney formation in the Osr1-KO mouse model (Table S5). RFP-positive rat ESCs (rDby-RFP) were injected into blastocysts obtained from Osr1-heterozygous mouse crossings (donor: rat; host: mouse), and the resulting chimeras were analyzed at E13.5 (Figures 5A and 5B). Rat chimeras derived from non-Osr1-KO genotypes occasionally exhibited fewer than two kidneys, irrespective of the contribution of rat cells in the chimeras (Figures S4B and S4C). We further investigated similar phenomena in chimeras generated by injecting the same rat ESCs into rat embryos (Table S6); however, all rat-rat chimeras consistently developed two kidneys, indicating that the rat ESCs used in this study did not cause any phenotypic alterations in kidney development (Figure S4D). In the chimeras with the Osr1-KO genotype, the rat chimeras could develop kidneys only under conditions of higher rat cell chimerism (Figure 5C). When rat ESCs were injected into mouse embryos, the chimerism observed in the kidney mirrored that in the tail, diverging from the pattern seen in the lung (Figure S4A). On the other hand, the distribution of chimerism in the kidney, tail, and lung was relatively uniform when rat ESCs were injected into rat embryos (Figure S4E). Therefore, we deduced that rat cell contribution in the kidney could be predicted from that in the tail, indicating that kidney formation in the Osr1-KO model requires a rat cell contribution rate in the tail exceeding 30%–40% (Figure 5D). Similar results, where the chimeras of non-Osr1-KO genotypes exhibiting an unexpected number of kidneys and chimeras with the Osr1-KO genotype manifesting kidney development only under higher rat chimerism, were observed in the different rat ESCs (rRFP5-2) (Figures S5A–S5D; Table S5). These findings imply that even rat ESCs could complement the kidney-deficient phenotype in mice if the necessary conditions are fulfilled. To determine whether the reconstructed rat kidneys consisted of NPCs and UB-derived tissues, as observed in the intraspecies BC method, we conducted an immunofluorescence experiment. The reconstituted kidney in the Osr1-KO model displayed RFP signals throughout, in contrast to kidneys from the non-Osr1-KO model (Figure 5E). Six2+ NPCs and E-Cad+ UB tissues were likely composed of RFP+ rat cells in the kidney obtained from the Osr1-KO model compared to that from the non-Osr1-KO model (Figure 5E). However, the lack of fluorescence signals in host-derived cells made it challenging to identify where non-fluorescent (host) cells contributed. Further analysis of the rat-derived kidneys from the Osr1-KO model using RT-PCR with mouse-specific primers—including NPCs marker Six2, UB marker Ret, and stroma marker Foxd1—revealed minimal detection of Six2 and Ret within the mouse cell population of Osr1-KO chimeras. Conversely, Foxd1 was detected in the mouse cell population of the Osr1-KO chimeras, similar to those in the non-Osr1-KO chimeras (Figure 5F). Moreover, when examining the proportional contribution of mouse and rat cells across kidney tissue components, we found that NPCs and UB cells were overwhelmingly dominated by rat cells in the Osr1-KO chimeras (Figure 5G). Furthermore, the reconstructed rat kidneys exhibited expression of markers of nephron tubules and early nephron development, including Lotus tetragonolobus lectin (LTL), WT1, E-cadherin, and Pax2, as well as the endothelial marker CD31, following in vitro kidney organ culture to promote maturation (Figures S6A and S6B). These results demonstrate that rat cells can indeed occupy the developmental niche present in Osr1-KO mouse models, provided that the conditions are conducive to kidney development. Interspecies BC method for generating rat kidney with the Osr1-KO mouse model (A) Schematic of the interspecies blastocyst complementation (BC) method. RFP-expressing rat ESCs were injected into the embryos obtained by crossing Osr1 heterozygous male with female mice (donor: rat; host: mouse). Chimeras derived from Osr1-KO mouse or non-Osr1-KO mouse and wild-type (WT) rat cells were dissected at E13.5. (B) Genotype results of interspecies blastocyst complementation. (C) Representative images of embryos and kidneys derived from chimeras generated from Osr1-KO embryos and rat ESCs (RFP+: rDby-RFP), showing high rat contribution (upper) and low rat contribution (lower). Chimeras with high rat contribution contained kidneys (black arrow) in the Osr1-KO background, and RFP-expressing kidneys were observed. Scale bars: 1 mm. (D) Relationship between the cellular contribution rate of the injected rat WT cells in tail and the number of the kidney in Osr1-KO and WT rat ESC chimeras. Osr1-KO-rat WT ESC chimeras with 2 kidneys (n = 4), 1 kidney (n = 3), and 0 kidney (n = 9) were analyzed. (E) Representative immunostaining image of E-Cad and Six2 in kidney of Osr1-KO and rat WT cell chimera or non-Osr1-KO and rat WT cell chimera. The kidney tissues were organ cultured for 5 days. Scale bars, 100 μm. (F) Quantitative reverse transcription polymerase chain reaction (RT-qPCR) analysis results for mouse Six2, Ret, and Foxd1 in the kidney derived from rDby-RFP chimeras and rRFP5-2 chimeras. Data were normalized to mouse Gapdh expression levels. Samples were extracted from the kidneys of chimeras. All values are expressed as mean ± standard deviation from at least triplicate experiments (Osr1-KO: n = 5 kidneys, non-KO: n = 7 kidneys). ∗∗p < 0.01; unpaired two-tailed Student’s t test. (G) Variation in the presence of rat cells in each kidney tissue component. Note that rat Six2 and Ret were predominantly detected compared with mouse genes but not rat Foxd1 in the rat Osr1-KO chimera (Osr1-KO: n = 5 kidneys, non-KO: n = 7 kidneys). Discussion In this study, we have elucidated the requisite conditions for successful kidney generation in various kidney-deficient models using the rBC method. Our results indicate that Sall1-KO cells are specifically incapable of contributing to NPCs, Ret-KO cells cannot contribute to UB cells, and Osr1-KO cells are unable to contribute to both NPCs and UB cells. Consequently, we infer that WT cells can complement these tissues in each respective model when performing the BC method. The required conditions for kidney generation in the Sall1-KO, Ret-KO, and Osr1-KO models were found to vary depending on the model. Notably, the Ret-KO model required the fewest WT cells for kidney development compared to the Sall1-KO and Osr1-KO models. This may be attributed to the occasional presence of hypoplastic kidneys even in Ret-KO mice (Schuchardt et al., 1994, 1996). The minimum threshold necessary in kidney generation with the rBC method may reflect the severity of each kidney-deficient model. The rBC method allowed us to analyze chimeras containing even double-gene KO (Ret/Sall1-KO) cells with 100% probability, a significant improvement in efficiency compared to the conventional method of crossing heterozygous mice, which yields only 1 in 16 (6.25%) embryos when targeting two genes. Noteworthily, the rBC method has the potential to analyze models with KOs of not only two genes but also multiple genes or complex gene modification for organ deficiencies, as it only requires the establishment of genetically modified ESCs. The implementation of this system would efficiently address the challenge of generating all cells of a target organ with PSC-derived cells. In previous studies, the kidney was found to be completely absent in Osr1-KO mice, although the nephric duct was formed but mildly affected (James et al., 2006). Osr1 is expressed in IM cells, which are nephric duct precursors, and in NPCs but not in the nephric duct and UB themselves (James et al., 2006). Thus, the nephric duct defects observed in Osr1-KO mice have been proposed to arise either from abnormalities in nephric duct precursors or from impaired interactions between the nephric duct and Osr1-expressing mesenchyme (Obara-Ishihara et al., 1999). In our analysis of chimeras containing Osr1-KO and WT cells, we found that Osr1-KO cells could not contribute to UB tissues, which differentiate from the nephric duct. This indicates that Osr1-KO cells indeed possess a defect in nephric duct precursor cells, rather than in the interaction between the duct and Osr1-expressing mesenchyme. Consequently, Osr1-KO cells were outcompeted by WT cells during differentiation into the nephric duct from Osr1-positive IM cells. Interestingly, an abnormal kidney phenotype was rarely observed in mouse-rat interspecies chimeras, where rat ESCs were injected into mouse embryos, similar to the previous study (Yamaguchi et al., 2018). The frequency of these phenotypes did not correlate with the level of rat ESC-derived cell chimerism. Since the phenotype was absent when rat ESCs were injected into rat embryos, it is likely that the abnormalities were not due to intrinsic defects in the injected rat ESCs but rather to incompatibilities between mouse and rat cells. These species-specific incompatibilities may include interspecies cellular interactions, mismatched ligand-receptor interactions, and other intrinsic or extrinsic cellular factors. Thus, the abnormalities in kidney development observed in these mouse-rat chimeras may provide important insights into organogenesis in future interspecies chimeras. A comprehensive understanding of these mechanisms may, for example, allow us to explore unusual interactions between heterologous cells and important pathways for organogenesis. We successfully achieved rat kidney reconstruction in a mouse kidney-deficient model with the interspecies BC method, contradicting previous reports that deemed this impossible (Usui et al., 2012). The inability of rat cells to develop in the mouse kidney-deficient model was previously attributed to their failure to integrate into MM tissues (Usui et al., 2012). Consistent with these prior observations, our study also found that rat cells rarely contributed to kidney tissues, including Six2+ NPCs. However, we found that rat cells occasionally surpassed the minimum threshold required for kidney generation in the Osr1-KO kidney-deficient model. Consequently, we were able to generate rat kidneys in the mouse kidney-deficient model when the contribution of rat cells was sufficiently high. If the difficulty of rat cells to contribute to mouse kidneys is improved, rat kidneys will be more easily created in the future. Since human cells are almost always difficult to contribute to other species organs (Wu et al., 2017; Strell et al., 2022; Wang et al., 2023), analysis and improvement of this problem in mouse-rat chimeras will make it possible to create human organs in xenogeneic animals in the future. We analyzed the rat-reconstructed kidneys only at E13.5 because chimeras harboring rat kidneys emerged only when rat cell contribution was high in the Osr1-KO model, and these high-rat-contribution chimeras did not survive beyond E14.5, likely due to cardiac abnormalities (Yuri et al., 2024a). The previous study (Usui et al., 2012), which discussed that rat cells cannot generate kidneys in the mouse kidney-deficient model, did not specify the timing of their analysis. Therefore, it is possible that chimeras containing rat kidneys may not have survived if analyzed later than E14.5. Another potential explanation for the absence of rat kidneys in the mouse kidney-deficient model in previous studies is the use of the Sall1-KO mouse model, which is deficient only in MM tissues. While rat cells can complement MM tissues in the Sall1-KO model, rat cells cannot completely complement to UB tissues, possibly leading to unsuitable interspecies interactions. Conversely, the Osr1-KO model used in this study is predominantly deficient in both MM and UB lineages, allowing rat cells to complement both lineages and thereby facilitating proper tissue interactions. Future studies employing ablation strategies targeting both MM and UB tissues will be important to extend and generalize this hypothesis beyond the Osr1-KO model used in this study. In this study, the analyses were restricted to embryonic stages (up to E13.5), as embryos with high levels of rat cell chimerism exhibited embryonic lethality, precluding the evaluation of postnatal maturation and renal function. The requirement for a high proportion of rat cell contribution in the kidney indicates that developmental incompatibility and interspecies cell competition continue to impede efficient complementation. Furthermore, the long-term structural and functional fidelity of the reconstructed kidneys, including nephron segmentation and urinary tract connectivity, has yet to be assessed. Future studies will be required to determine whether BC-derived kidneys can undergo vascularization, structural maturation, and functional integration following transplantation into host animals, as demonstrated for embryonic kidney rudiments at comparable developmental stages (Dekel et al., 1997, 2002, 2003). Finally, although the Osr1-KO model predominantly lacks both MM and UB lineages, it may not represent a completely anephric state, as non-MM/UB components such as stromal or endothelial cells could persist and influence the patterning of complemented tissues. Alternative or conditional kidney-deficient models may be necessary to achieve a fully anephric state and refine the developmental niche for renal complementation. To assess potential host cell contribution, single-cell and spatially resolved analyses will also be important to more precisely define donor-host contributions across renal compartments. Addressing these limitations will be critical for evaluating the functional potential of interspecies kidney generation and improving cross-species developmental compatibility. Resource availability Lead contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Shunsuke Yuri (shunsukeyuri@ncgg.go.jp). Materials availability Cell lines and mouse lines generated in this study are available with a material transfer agreement. Requests should be directed to the lead contact. Data and code availability •This study did not generate any unique dataset. This study did not generate any unique dataset. •This study did not generate any original code. This study did not generate any original code. •All used software is listed in the key resources table. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon reasonable request. All used software is listed in the key resources table. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon reasonable request. Acknowledgments We thank the members of Isotani Laboratory in NAIST and the members of Laboratory of Experimental Animals in NCGG for their helpful assistance and discussions. The LiSCO at the Nara Institute of Science and Technology (NAIST) and the core facility at National Center for Geriatrics and Gerontology (NCGG) were instrumental in this study. We appreciate Dr. Masahito Ikawa (Osaka University) for kindly providing the pCX-EGFP plasmid, pCX-hCre plasmid, R01 ESC, and rGBGS #6 (F344) rats. This study was supported by grants from the Japan Society for the Promotion of Science KAKENHI (grant nos. 23K18577 and 24K01948 to A.I. and 18K06031, 22K06067, and 25K02202 to S.Y.), KAC 40th Anniversary Research grant to A.I., the Novartis Foundation (Japan) for the Promotion of Science to A.I., and the Foundation for Nara Institute of Science and Technology to S.Y., and the Research Fund for Longevity Sciences from the NCGG (24–31). Author contributions Conceptualization, S.Y. and A.I.; methodology, S.Y.; validation, S.Y. and A.I.; formal analysis, S.Y.; investigation, S.Y. and A.I.; writing – original draft, S.Y.; writing – review and editing, S.Y. and A.I.; visualization, S.Y.; supervision, A.I.; funding acquisition, S.Y. and A.I. Declaration of interests The authors declare no competing interests. STAR★Methods Key resources table REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesSIX2 Polyclonal antibody (dilution 1:100)Proteintech11562-1-APRRID: AB_2189084Purified Mouse Anti-E-Cadherin antibody (dilution 1:100)BD Transduction Laboratories610181RRID: AB_397581Pbx1 Antibody (dilution 1:100)Cell Signaling Technology4342RRID: AB_2160295Endomucin (V.7C7)(dilution 1:100)Santa Cruz Biotechnologysc-65495RRID: AB_2100037WT1 (Wilms Tumor Protein) antibody(dilution 1:100)Abcamab89901RRID: AB_2043201Purified anti-Pax-2 Antibody (dilution 1:100)Biolegend901001RRID: AB_2734656CD31/PECAM-1 Antibody (dilution 1:100)R and D SystemsAF3628RRID: AB_2161028Goat Alexa Fluor 647 anti-rabbit IgG (dilution 1:1000)Thermo Fisher ScientificA11017RRID: AB_2535814Goat Alexa Fluor 647 anti-mouse IgG (dilution 1:1000)Thermo Fisher ScientificA21237RRID: AB_2535806Goat Alexa Fluor 647 anti-rat IgG (dilution 1:1000)Thermo Fisher ScientificA21247RRID: AB_141778Donkey Anti-Rabbit IgG H&L (Alexa Fluor® 647)(dilution 1:500-1:1000)Abcamab150075RRID: AB_2752244Donkey Anti-Mouse IgG H&L (Alexa Fluor® 647)(dilution 1:500-1:1000)Abcamab150107RRID: AB_2535806Donkey Anti-Goat IgG H&L (Alexa Fluor 647)(dilution 1:500-1:1000)Abcamab150135RRID: AB_2687955Lotus Tetragonolobus Lectin (LTL), Biotinylated(dilution 1:100)VectorB-1325-2Streptavidin, Alexa Fluor™ 647 Conjugate (dilution 1:500)Thermo Fisher ScientificS21374Chemicals, peptides, and recombinant proteinsCHIR99021Axon1386CGP77675SigmaSML0314PD0325901Wako162–25291N2Thermo Fisher Scientific17502048B27Thermo Fisher Scientific17504044CARD HyperOvaKyudo1.0mLPuromycinSigmaP9620Hoechst33342DojindoKV072Opti-MEMThermo Fisher Scientific319850622.5% TrypsinNacalai Tesque18172–94Critical commercial assaysTrizol reagentThermo Fisher Scientific15596026SuperScript IV VILO master mixThermo Fisher Scientific11756050GoTaq® Green Master MixPromegaM712KOD Fx NeoTOYOBOKFX-201Q5 High-Fidelity DNA polymeraseNEBM0491SLuna Universal qPCR Master MixNEBM3003LLipofectamine 3000Thermo Fisher ScientificL3000008Experimental models: Cell linesR01-09 ESC lineYuri et al. (2024b)N/AR01 ESC lineprovided from Dr. Ikawa.N/ArDby-RFP rat ESC lineThis studyN/ArRFP5-2 rat ESC lineThis studyN/ASall1-KO ESC linesThis studyN/ARet-KO ESC linesThis studyN/ARet/Sall1-DKO ESC linesThis studyN/AOsr1-KO ESC linesThis studyN/AExperimental models: Organisms/strainsMouse: Osr1-GFPThis studyN/AMouse: Osr1-CreThis studyN/AOligonucleotidesSee Tables S1 and S2N/AN/ARecombinant DNApSpCas9(BB)-2A-Puro (pX459) V2.0 plasmidsAddgene#62988pLSODN-4DBioDynamics Laboratory Inc.DS620Software and algorithmsCrisperDirectN/Ahttps://crispr.dbcls.jp/ImageJ-Fiji softwareNIH imageshttps://imagej.nih.gov/ij/ Experimental model and study participant details Animals All animal experiments were conducted in accordance with the guidelines of “Regulations and By-Laws of Animal Experimentation at the Nara Institute for Science and Technology” and were approved by the Animal Experimental Committee at the Nara Institute of Science and Technology (approval no. 2109 and no 0.2103) and NCGG Animal Ethics Committee (approval no. 7–13). Heterozygous of Osr1-GFP or Osr1-Cre mouse line were established from chimeras that Osr1-GFP ESCs or Osr1-Cre ESCs derived from R01 ESCs were injected into ICR embryo at E2.5 stage. After establishment of Osr1-GFP or Osr1-Cre mouse lines, B6D2F1 mice were used for backcrossing. B6D2F1 and ICR mice were purchased from Japan SLC, Inc. Cell culture For the establishment of Sall1-KO ESC lines, two different gRNAs were designed to delete the entire exon region of Sall1 gene. The two plasmids were then transfected into R01-09 ESCs, which used in previous study (Yuri et al., 2024a, 2024b), using Lipofectamine 3000 (Thermo Fisher Scientific). To establish Ret-KO ESC lines, a DNA fragment which contain EGFP-polyA sequence was inserted into the Ret gene. The EGFP sequence was inserted in-frame within the Ret gene. To enhance homologous recombination, a gRNA was designed close to knock-in site of the Ret gene. Two different plasmids—the targeting vector and the plasmid inducing a double-strand break in genomic DNA—were then transfected into R01-09 ESCs. For Osr1-GFP or Osr1-Cre ESC lines, the EGFP-polyA or hCre-polyA sequence was inserted into the Osr1 gene. The EGFP or hCre sequence was inserted in-frame within the Osr1 locus. Similarly to Ret-KO ESCs, a gRNA was designed close to knock-in site of the Osr1 gene. Two different plasmids were then transfected into R01 ESCs. Transfected cells were cultured with transient treatment using 1 μg/mL puromycin (Sigma) for 2 days and then passaged for clonal culture. ESC colonies were subjected to genotyping by PCR and sequencing. ESCs were cultured on gelatin- and MEF (mouse embryonic fibroblast)-coated dish in N2 (Gibco) and B27 medium (Gibco) supplemented with 3 μM CHIR99021 (AXON), 1.5 μM CGP77675 (SIGMA), and mouse LIF (NPO in Osaka University) (N2B27-a2i/L medium). Osr1-KO ESC lines were established from blastocysts obtained by crossing Osr1-GFP and Osr1-Cre mouse line and were cultured in N2B27-a2i/L medium (Yagi et al., 2017; Choi et al., 2017). A rat ESC line, rDby-RFP, was established from blastocysts obtained by crossing DA female with rGBGS#6 (F344) male rats (Isotani et al., 2016) and was cultured with N2B27 medium supplemented with 3 μM CHIR99021, 1.5 μM PD0325901 (Wako), mouse LIF and human LIF (Sigma) (N2B27-2i/L medium). A CAG-tdTomato-T2A-puroR cassette was subsequently inserted into genomic DNA between introns 1 and 2 of the Ddx3y locus. Another rat ESC line, rRFP5-2, was similarly derived from blastocysts obtained by crossing DA females with rGBGS#6 (F344) males. The pCAG-tdTomato-T2A-puroR plasmid was transfected into the established male ESCs, followed by puromycin selection for seven days, resulting in a stable ESC line with constitutive tdTomato expression. These rat ESCs were cultured on gelatin (Sigma)- or matrigel (Corning)- and MEF-coated dishes in N2B27-2i/L medium (Ying et al., 2008). These cell lines were cultured under sterile conditions and tested negative for mycoplasma contamination. The cell source is provided in key resources table. Method details Plasmid construction The oligo DNAs for the target gRNA sequence of Sall1, Ret, and Osr1 genes (Table S7) were inserted into BbsI site of the pSpCas9(BB)-2A-Puro (pX459) V2.0 plasmid, which was a gift from Feng Zhang through Addgene (plasmid # 62988) (Ran et al., 2013). The target sites were designed using the CrisperDirect website to identify specific target sites (Naito et al., 2015). For the Ret-GFP plasmid, left-arm and MluI site + right-arm PCR fragments were inserted into the EcoRV site of the pLSODN-4D plasmid (BioDynamics Laboratory Inc.) using the SLiCE method (Motohashi et al., 2015). The EGFP-polyA fragment was then inserted into the MluI site using the SLiCE method. For the Osr1-GFP plasmid, the left-arm, EGFP-polyA, and right-arm fragments were simultaneously inserted into the EcoRV site of the pLSODN-4D plasmid using SLiCE method. For the Osr1-Cre plasmid, left-arm, hCre-polyA, and right-arm fragments were simultaneously inserted into the EcoRV site of pLSODN-4D plasmid using the SLiCE method. EGFP-polyA or hCre-polyA fragment was amplified from pCX-EGFP or pCX-hCre provided from Dr. Masahito Ikawa (Osaka University), respectively. For the rDby-RFP plasmid, the 3′-arm PCR fragment was inserted into the SpeI site of pCAG-tdTomato-2A-PuroR (Hirata et al., 2022) using the SLiCE method, followed by insertion of the 5′-arm PCR fragment into the HindIII site. The oligo DNAs for the target gRNA sequence of rat Ddx3y gene (Table S7) were inserted into BbsI site of the pSpCas9(BB)-2A-Puro (pX459) V2.0 plasmids. PCR fragments were amplified with Q5 High-Fidelity DNA polymerase (New England Biolabs) or KOD FX Neo (Toyobo). Primer information for plasmid construction is stated in Table S7. Genotyping Primers for detecting Sall1-KO, Ret-KO, Osr1-KO and rDby-RFP are listed in Table S7. Primers for detecting Osr1-GFP and Osr1-Cre mice are also shown in Table S7. DNA fragments were amplified using GoTaq (Promega) for 40 cycles to detect null or WT alleles under the following conditions: 94°C for 30 s, 60°C for 30 s and 72°C for 30–90 s. DNA fragments for Sall1-KO detection were amplified using KOD FxNeo (Toyobo). ESCs injection ICR, Osr1-GFP or Osr1-Cre female mice aged at 8–12 weeks were treated with CARD HyperOva and hCG for superovulation and then mated with ICR or Osr1-GFP or Osr1-Cre male mice, respectively. Two-cell-stage embryos were collected from the oviduct of female mice 42–46 h after hCG injection using the flush-out method. The collected embryos were incubated in KSOM medium at 37°C under 5% CO2 conditions until injection was performed. The rBC method was performed as described in previous reports (Yuri et al., 2024a, 2024b). Briefly, 6–8 cells of Sall1-KO, Ret-KO or Osr1-KO ESCs were injected into ICR embryos at 8-cell-stage. For the intraspecies BC method with mouse embryos, 6–8 cells of R01-09 ESCs were injected into embryos obtained from intercrosses between Osr1-GFP and Osr1-Cre mice at the E3.5 stage. For interspecies BC method, 4 cells of rDby-RFP or rRFP5-2 ESCs were injected into embryos obtained from matings between Osr1-GFP and Osr1-Cre mice at the E3.5 stage. The injected embryos were transferred into the uteri of E2.5 pseudopregnant ICR mice. For rat ESC injection into rat embryos, Wistar-Imamichi males and females were naturally mated to obtain blastocysts. The blastocysts were then injected by 4–6 rDby-RFP ESCs and transferred into the uteri of E3.5 pregnant Wistar-Imamichi rats. Embryos were dissected at E13.5 or E14.5 for mouse experiments and at E15.5 for the rat experiments. Chimeras were analyzed based on RFP or GFP signal under a fluorescent stereomicroscope (Leica; MZFL III). Flow cytometry analysis and fluorescence-assisted cell sorting For mouse–mouse ESCs or mouse–rat ESCs chimera experiments, embryos were recovered at the E14.5 or E13.5 stage. For rat–rat ESCs chimera experiments, embryos were recovered at the E15.5 stage. Tail, lung, or kidney samples were incubated with 0.25% trypsin/EDTA for 10 min at 37°C. After pipetting to dissociate the tissues, 10% FBS in PBS was added, and the cell suspensions were filtered through a 37-μm mesh. The FL3 detector on an Accuri flow cytometer (BD Bioscience) or the ECD detector on a CytoFLEX S flow cytometer (Beckman coulter) was used to detect RFP+ populations. An MA900 cell sorter (SONY) was used to isolate RFP+ and RFP- subpopulations for RT-PCR analysis. RNA expression analysis Total RNA was purified using TRIzol reagent (Thermo Fisher Scientific). cDNA was synthesized using the SuperScript IV VILO master mix (Thermo Fisher Scientific). For quantitative RT-PCR analysis, Luna Universal qPCR Master Mix (New England Biolabs) was used for amplification, and amplified products were detected using a LightCycler 96 (Roche). The species specificity of all primer sets was evaluated based on the amplification and melting curves obtained from qPCR results. Primers used for RT-PCR are listed in Table S8. Immunocytochemistry staining The kidneys at E14.5 were fixed with 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) (−) (Nacalai) for overnight at 4°C. After washing with PBS (−), the tissues were immersed in 10, 15, and 20% sucrose in PBS (−). The treated tissues were then sunk into Tissue-TeK O.C.T compound (Sakura Finetek). After making sections with a cryostat (Leica; NX70) at 10 μm thickness, the slides were dried at 25°C, followed by washing with PBS (−). In the mouse–rat chimera experiments, the kidneys were cultured on 0.4 μm isopore polycarbonate filter (Millipore) with DMEM supplemented with 10% FBS for 5–7 days and then fixed and analyzed as same protocol as described above. For Immunostaining method were previously described (Yuri et al., 2024a, 2024b). The antibodies used in this study were listed in key resources table. Immunostained slides were observed using a laser confocal microscope (LSM710, LSM900; Zeiss, Mica; Leica). Quantification and statistical analysis Statistical analysis For quantification of immunostaining, different nonoverlapped regions were analyzed in each marker. Statistical analyses were performed by unpaired Student’s t test with significance at ∗: p < 0.05, ∗∗: p < 0.01. Error bars represent mean ± standard deviation (SD). For quantitative RT-PCR data expressed as relative fold changes, all values are expressed as mean ± standard deviation from at least triplicate experiments. Student’s t test for unpaired comparisons was performed and results at p < 0.01 were considered statistically significant. Published: June 11, 2026 Footnotes Supplemental information can be found online at https://doi.org/10.1016/j.stemcr.2026.102957. Contributor Information Shunsuke Yuri, Email: shunsukeyuri@ncgg.go.jp. Ayako Isotani, Email: isotani@bs.naist.jp. Supplemental information Document S1. Figures S1–S6 and Tables S1–S8 Document S2. Article plus supplemental information References Associated Data Supplementary Materials Document S1. Figures S1–S6 and Tables S1–S8 Document S2. Article plus supplemental information Data Availability Statement •This study did not generate any unique dataset. This study did not generate any unique dataset. •This study did not generate any original code. This study did not generate any original code. •All used software is listed in the key resources table. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon reasonable request. All used software is listed in the key resources table. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon reasonable request.